Gentler treatment tested for older patients with blood cancer

NCT ID NCT05977673

Summary

This study is testing a drug called tislelizumab as a first treatment for older adults with Hodgkin lymphoma who are not healthy enough for standard chemotherapy. The goal is to see if this single, immunotherapy drug can effectively control the cancer with fewer side effects. Researchers will measure how well the cancer responds and how long the response lasts in about 28 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia

    RECRUITING

    Alessandria, IT, Italy

    Contact Email: •••••@•••••

    Contact

  • Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano

    RECRUITING

    Aviano, Italy

    Contact Email: •••••@•••••

    Contact

  • Ematologia, Fondazione IRCCS Istituto Nazionale Dei Tumori

    RECRUITING

    Milan, Italy

    Contact Email: •••••@•••••

    Contact

  • Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione, Azienda Ospealiero Universitaria Policlinico Umberto I

    RECRUITING

    Roma, Italy

    Contact Email: •••••@•••••

    Contact

  • Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi

    RECRUITING

    Bologna, Italy

    Contact Email: •••••@•••••

    Contact

  • Oncoematologia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

    NOT_YET_RECRUITING

    Palermo, Italy

    Contact Email: •••••@•••••

    Contact

  • Oncologia, IRCCS Istituto Nazionale Tumori Fondazione Pascale

    RECRUITING

    Naples, Italy

    Contact Email: •••••@•••••

    Contact

  • SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

    RECRUITING

    Brescia, Italy

    Contact Email: •••••@•••••

    Contact

  • U.O di Oncologia Medica ed Ematologia, Humanitas Research Hospital

    RECRUITING

    Rozzano, Italy

    Contact Email: •••••@•••••

    Contact

  • Unità di Ematologia e TMO - Unità Linfomi, Ospedale San Raffaele

    RECRUITING

    Milan, Italy

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.